Dear AuntMinnie Member,
A new study published today in Radiology not only reaffirms that screening mammography saves lives, but also that screening's mortality reduction actually increases as women get older.
The new results come from the landmark Swedish Two-County Trial, which in the past has demonstrated mammography's effectiveness in reducing deaths from breast cancer, particularly for women ages 40 to 49. What's new about this week's study is that mammography's mortality benefit is higher -- a 30% reduction in deaths, compared with 28% in previous studies -- and that the benefit increased over time.
The researchers found that in a patient cohort followed for almost 30 years, most of the cancer deaths prevented would have occurred more than a decade after screening started.
The study serves as a rebuttal to the controversial 2009 screening guidelines released by the U.S. Preventive Services Task Force (USPSTF), which rescinded a recommendation that screening begin at age 40. Learn more in our Women's Imaging Digital Community by clicking here.
In other news in the community, we're featuring an article on the challenges presented by the BI-RADS 3 category, "probably benign." Women whose lesions are classified as BI-RADS 3 should be followed up, but many don't comply. Learn how to handle this dilemma by clicking here.
Finally, learn about the latest round of consolidation in women's imaging by clicking here, or visit our Women's Imaging Digital Community at women.auntminnie.com.







![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&fit=crop&h=112&q=70&w=112)






